In brief, treatment with fluoxetine, as described above, that increases the levels of TGF-β may lead to an increase in FAM3C, then in M-neurons, and finally to neurogenesis, which should benefit the attempt to the reverse AD. Here, TGFB1 is linked to Alzheimer disease.